Investigating a new way to predict atrial fibrillation risk using heart rate patterns
Heart Rate Fragmentation: New Biomarker of Atrial Fibrillation Risk
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-10442503
This study is looking at how certain heart rate patterns can help us find hidden episodes of atrial fibrillation (AF) in patients with heart monitoring devices, which could lead to better understanding and management of this common heart condition.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10442503 on ClinicalTrials.gov |
What this research studies
This research focuses on atrial fibrillation (AF), a common heart rhythm disorder that can lead to serious health issues like stroke and heart failure. The study aims to identify new biomarkers by analyzing heart rate fragmentation metrics from long-term electrocardiographic recordings. By using data from patients with implanted monitoring devices, the research seeks to uncover undetected AF episodes and their potential complications. This approach could help in understanding the relationship between heart rate patterns and the risk of developing AF.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with risk factors for atrial fibrillation or those who have had undetected episodes of AF.
Not a fit: Patients who do not have any risk factors for atrial fibrillation or those with a history of clinically recognized AF may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of atrial fibrillation and its associated risks, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using heart rate metrics to predict arrhythmias, suggesting that this approach may yield valuable insights.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HECKBERT, SUSAN R — UNIVERSITY OF WASHINGTON
- Study coordinator: HECKBERT, SUSAN R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cardiovascular Diseases, cardiovascular disorder